APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 35 filers reported holding APTEVO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $515 | -77.0% | 1,562 | +2.0% | 0.00% | – |
| Q2 2023 | $2,235 | -31.9% | 1,531 | -5.1% | 0.00% | – |
| Q1 2023 | $3,284 | -12.2% | 1,614 | +0.1% | 0.00% | – |
| Q4 2022 | $3,742 | -25.2% | 1,613 | -8.0% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 1,754 | +12.5% | 0.00% | – |
| Q2 2022 | $5,000 | -44.4% | 1,559 | +0.3% | 0.00% | – |
| Q1 2022 | $9,000 | -25.0% | 1,555 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -50.0% | 1,555 | +0.2% | 0.00% | – |
| Q3 2021 | $24,000 | -31.4% | 1,552 | -0.1% | 0.00% | – |
| Q2 2021 | $35,000 | -25.5% | 1,554 | +0.1% | 0.00% | – |
| Q1 2021 | $47,000 | -17.5% | 1,553 | +0.1% | 0.00% | – |
| Q4 2020 | $57,000 | +1800.0% | 1,552 | +241.1% | 0.00% | – |
| Q3 2020 | $3,000 | -25.0% | 455 | +1.1% | 0.00% | – |
| Q2 2020 | $4,000 | – | 450 | +1700.0% | 0.00% | – |
| Q1 2020 | $0 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,760,000 | $64,504,000 | 9.85% |
| Stonepine Capital Management, LLC | 18,280 | $670,000 | 0.51% |
| Ghost Tree Capital, LLC | 50,000 | $1,833,000 | 0.41% |
| Anson Funds Management LP | 45,462 | $1,666,000 | 0.34% |
| RTW INVESTMENTS, LP | 288,236 | $10,564,000 | 0.18% |
| Dynamic Technology Lab Private Ltd | 13,202 | $484,000 | 0.08% |
| Alyeska Investment Group, L.P. | 49,601 | $1,818,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11,493 | $421,000 | 0.02% |
| PURA VIDA INVESTMENTS, LLC | 8,203 | $301,000 | 0.01% |
| Renaissance Technologies | 254,423 | $9,325,000 | 0.01% |